Retroperitoneoscopic One-Trocar-Assisted Pyeloplasty in Children: An Age-Related Evaluation

Giovanni Cobellis1, Fabiano Nino1, Francesco Pierangeli1

  • 1Pediatric Surgery Unit, Salesi Children's Hospital, Università Politecnica delle Marche , Ancona, Italy .

Insights

Retroperitoneoscopic one-trocar-assisted pyeloplasty (OTAP) is effective for pediatric ureteropelvic junction obstruction in children under 6 years. Older children experienced longer operative times and higher conversion rates with OTAP.

Area of Science:

  • Pediatric Urology
  • Minimally Invasive Surgery
  • Surgical Outcomes

Background:

  • Ureteropelvic junction (UPJ) obstruction is a common cause of hydronephrosis in children.
  • Pyeloplasty is the gold standard surgical treatment for UPJ obstruction.
  • Retroperitoneoscopic one-trocar-assisted pyeloplasty (OTAP) offers a minimally invasive approach.

Purpose of the Study:

  • To evaluate the efficacy of retroperitoneoscopic one-trocar-assisted pyeloplasty (OTAP).
  • To assess OTAP outcomes in pediatric patients across different age groups.

Main Methods:

  • Retrospective review of 70 children undergoing OTAP for UPJ obstruction (2006-2014).
  • Patients were stratified into three age groups: <2 years, 2-6 years, and >6 years.
  • Surgical management, operative time, conversion rates, and recurrence were analyzed.

Main Results:

  • No intraoperative complications were reported.
  • Mean operative time was significantly longer in children older than 6 years compared to younger groups.
  • Conversion rates were highest in the oldest age group (56.25%).
  • Recurrence was observed in 3 patients (2 in the youngest group, 1 in the oldest).

Conclusions:

  • OTAP is a viable and effective treatment for UPJ obstruction in children younger than 6 years.
  • OTAP presents greater challenges in older children due to anatomical factors.
  • Further research may explore modifications for optimizing OTAP in older pediatric populations.
Abstract